Rapamycin improves Graves’ orbitopathy by suppressing CD4+ cytotoxic T lymphocytes-Reference-Cited by-同舟云学术

Rapamycin improves Graves’ orbitopathy by suppressing CD4+ cytotoxic T lymphocytes

Published:2023-02-08 Issue:3 Volume:8 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Zhang Meng,Chong Kelvin K.L.^ORCID,Chen Zi-yi,Guo Hui,Liu Yu-feng,Kang Yong-yong,Li Yang-jun,Shi Ting-ting,Lai Kenneth K.H.,He Ming-qian,Ye Kai,Kahaly George J.,Shi Bing-yin,Wang Yue

Funder

the National Key R&D Program of China

Natural Science Foundation of Shaanxi Province

China Postdoctoral Science Foundation

Clinical research award of the first affiliated hospital of Xi’an Jiaotong university

National Science Foundation of China

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/160377/files/pdf

Reference50 articles.

1. Graves’ disease

2. Graves' Ophthalmopathy

3. New insights into the pathogenesis and nonsurgical management of Graves orbitopathy

4. Pathogenesis of thyroid eye disease: review and update on molecular mechanisms

5. Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Orbital radiotherapy with combined intravenous methylprednisolone and mycophenolate mofetil in moderate-to-severe thyroid eye disease;AJO International;2024-07

2. Remodeling of T-cell mitochondrial metabolism to treat autoimmune diseases;Autoimmunity Reviews;2024-06

3. Interdisziplinäre Therapie der Erkrankungen der Orbita;Laryngo-Rhino-Otologie;2024-05

4. Ocular surface and meibomian gland evaluation in euthyroid Graves’ ophthalmopathy;International Ophthalmology;2024-03-02

5. Current and promising therapies based on the pathogenesis of Graves’ ophthalmopathy;Frontiers in Pharmacology;2023-11-16